105 related articles for article (PubMed ID: 38947813)
1. In Silico Drug Repurposing Uncovered the Antiviral Potential of the Antiparasitic Drug Oxibendazole Against the Chikungunya Virus.
Rabelo VW; Sanchez-Nuñez ML; Corrêa-Amorim LS; Kuhn RJ; Abreu PA; Paixão ICNP
ACS Omega; 2024 Jun; 9(25):27632-27642. PubMed ID: 38947813
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, antiviral evaluation, and In silico studies of acrylamides targeting nsP2 from Chikungunya virus.
Souza BG; Choudhary S; Vilela GG; Passos GFS; Costa CACB; Freitas JD; Coelho GL; Brandão JA; Anderson L; Bassi ÊJ; Araújo-Júnior JX; Tomar S; Silva-Júnior EFD
Eur J Med Chem; 2023 Oct; 258():115572. PubMed ID: 37364511
[TBL] [Abstract][Full Text] [Related]
3. Repurposing potential of rimantadine hydrochloride and development of a promising platinum(II)-rimantadine metallodrug for the treatment of Chikungunya virus infection.
Santos IA; Pereira AKDS; Guevara-Vega M; de Paiva REF; Sabino-Silva R; Bergamini FRG; Corbi PP; Jardim ACG
Acta Trop; 2022 Mar; 227():106300. PubMed ID: 34979144
[TBL] [Abstract][Full Text] [Related]
4. Drug repurposing approach against chikungunya virus: an
Kasabe B; Ahire G; Patil P; Punekar M; Davuluri KS; Kakade M; Alagarasu K; Parashar D; Cherian S
Front Cell Infect Microbiol; 2023; 13():1132538. PubMed ID: 37180434
[TBL] [Abstract][Full Text] [Related]
5. Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway.
Bouma EM; van de Pol DPI; Sanders ID; Rodenhuis-Zybert IA; Smit JM
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321803
[TBL] [Abstract][Full Text] [Related]
6. Design and Validation of Novel Chikungunya Virus Protease Inhibitors.
Das PK; Puusepp L; Varghese FS; Utt A; Ahola T; Kananovich DG; Lopp M; Merits A; Karelson M
Antimicrob Agents Chemother; 2016 Dec; 60(12):7382-7395. PubMed ID: 27736770
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Chikungunya virus early replication by intracellular nanoantibodies targeting nsP2 Epitope Rich Region.
Deng Q; Guo Z; Hu H; Li Q; Zhang Y; Wang J; Liao C; Guo C; Li X; Chen Z; Lu J
Antiviral Res; 2022 Dec; 208():105446. PubMed ID: 36270543
[TBL] [Abstract][Full Text] [Related]
8. 4'-Fluorouridine inhibits alphavirus replication and infection
Yin P; May NA; Lello LS; Fayed A; Parks MG; Drobish AM; Wang S; Andrews M; Sticher Z; Kolykhalov AA; Natchus MG; Painter GR; Merits A; Kielian M; Morrison TE
mBio; 2024 Jun; 15(6):e0042024. PubMed ID: 38700353
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo studies reveal α-Mangostin, a xanthonoid from Garcinia mangostana, as a promising natural antiviral compound against chikungunya virus.
Patil P; Agrawal M; Almelkar S; Jeengar MK; More A; Alagarasu K; Kumar NV; Mainkar PS; Parashar D; Cherian S
Virol J; 2021 Feb; 18(1):47. PubMed ID: 33639977
[TBL] [Abstract][Full Text] [Related]
10. Antiviral evaluation of 1,4-disubstituted-1,2,3-triazole derivatives against Chikungunya virus.
Rabelo VW; da Silva VD; Sanchez Nuñez ML; Dos Santos Corrêa Amorim L; Buarque CD; Kuhn RJ; Abreu PA; Nunes de Palmer Paixão IC
Future Virol; 2023 Sep; 18(13):865-880. PubMed ID: 37974899
[TBL] [Abstract][Full Text] [Related]
11. Indole alkaloids inhibit zika and chikungunya virus infection in different cell lines.
Monsalve-Escudero LM; Loaiza-Cano V; Pájaro-González Y; Oliveros-Díaz AF; Diaz-Castillo F; Quiñones W; Robledo S; Martinez-Gutierrez M
BMC Complement Med Ther; 2021 Aug; 21(1):216. PubMed ID: 34454481
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of silymarin against chikungunya virus.
Lani R; Hassandarvish P; Chiam CW; Moghaddam E; Chu JJ; Rausalu K; Merits A; Higgs S; Vanlandingham D; Abu Bakar S; Zandi K
Sci Rep; 2015 Jun; 5():11421. PubMed ID: 26078201
[TBL] [Abstract][Full Text] [Related]
13. Explorations on the antiviral potential of zinc and magnesium salts against chikungunya virus: implications for therapeutics.
Davuluri KS; Shukla S; Kakade M; Cherian S; Alagarasu K; Parashar D
Front Cell Infect Microbiol; 2024; 14():1335189. PubMed ID: 38895735
[TBL] [Abstract][Full Text] [Related]
14. Imidazonaphthyridine effects on Chikungunya virus replication: Antiviral activity by dependent and independent of interferon type 1 pathways.
Ruiz UEA; Santos IA; Grosche VR; Fernandes RS; de Godoy AS; Torres JDA; Freire MCLC; Mesquita NCMR; Guevara-Vega M; Nicolau-Junior N; Sabino-Silva R; Mineo TWP; Oliva G; Jardim ACG
Virus Res; 2023 Jan; 324():199029. PubMed ID: 36565816
[TBL] [Abstract][Full Text] [Related]
15. 1,3-Thiazolbenzamide Derivatives as Chikungunya Virus nsP2 Protease Inhibitors.
Ivanova L; Rausalu K; Žusinaite E; Tammiku-Taul J; Merits A; Karelson M
ACS Omega; 2021 Mar; 6(8):5786-5794. PubMed ID: 33681617
[TBL] [Abstract][Full Text] [Related]
16.
Chaudhary M; Sehgal D
J Biomol Struct Dyn; 2022; 40(22):11560-11570. PubMed ID: 34355667
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection.
Oo A; Rausalu K; Merits A; Higgs S; Vanlandingham D; Bakar SA; Zandi K
Antiviral Res; 2018 Feb; 150():101-111. PubMed ID: 29269135
[TBL] [Abstract][Full Text] [Related]
18. Repurposed drugs in combinations exert additive anti-chikungunya virus activity: an in-vitro study.
Davuluri KS; Ghanghav R; Ahire G; Kakade M; Cherian S; Alagarasu K; Parashar D
Virol J; 2024 Jan; 21(1):5. PubMed ID: 38178163
[TBL] [Abstract][Full Text] [Related]
19. Current Strategies for Inhibition of Chikungunya Infection.
Subudhi BB; Chattopadhyay S; Mishra P; Kumar A
Viruses; 2018 May; 10(5):. PubMed ID: 29751486
[TBL] [Abstract][Full Text] [Related]
20. Ethyl palmitate, an anti-chikungunya virus principle from Sauropus androgynus, a medicinal plant used to alleviate fever in ethnomedicine.
Sagna A; Nair RVR; Hulyalkar N; Rajasekharan S; Nair VTG; Sivakumar KC; Suja SR; Baby S; Sreekumar E
J Ethnopharmacol; 2023 Jun; 309():116366. PubMed ID: 36914036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
